Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19
Background The weakened immune system of patients on hemodialysis (HD) may prolong SARS-CoV-2 infection compared to the general population. Current international guidelines recommend ending isolation in conjunction with serial testing in moderately and severely immunocompromised subjects. This study aimed to estimate SARS-CoV-2 infectivity by measuring RT-PCR test positivity in HD patients. A comparison between RT-PCR test and cycle threshold (Ct) value has been performed as a secondary endpoint. Methods A single-center retrospective study was conducted at the University of Modena (Italy) from March 2020 to October 2022. Only patients on chronic HD therapy with COVID-19 were enrolled in the study. In our HD Center, two negative nasopharyngeal reverse transcription polymerase chain reaction (RT-PCR) results were used to end quarantine in this population. SARS-CoV-2 RT-PCR test positivity duration measured the time elapsed from a positive RT-PCR to a second negative test. Ct cut-off of 35 cycles was used to definite “high Ct value,” a condition characterized by a large number of cycles of PCR amplification to register a positive RT-PCR test. Results During the observational period, 159 cases of SARS-CoV-2 infections were diagnosed in 151 patients. Median age was 70.1 (54.3–81.6) years and males accounted for 59.6% of the COVID-19 population. Median duration of SARS-CoV-2 RT-PCR test positivity on the nasal mucosa accounted for 30 (IQR, 21–40.5) days. Unvaccinated patients experienced significantly longer RT-PCR test positivity compared to vaccinated patients (42 [IQR,31–56] vs. 28 [IQR,20–35.7] days; p = < 0.001). The use of high Ct value, a laboratory surrogate of SARS-CoV-2 replication, anticipated a negative RT-PCR test of 9 (IQR, 6–12) days. Multivariate linear regression analysis showed that increased age (β coefficient 0.31; confidence interval [CI] 95%, 0.14—0.43; p = < 0.001) and the lack of anti-SARS-CoV-2 vaccination (β 0.49 CI95%, 11.9–22.5; p = < 0.001) were predictors of a prolonged RT-PCR positivity. Conclusions Patients with COVID-19 on HD had prolonged RT-PCR test positivity. The adoption of “high Ct value” criteria led to a significant reduction in the duration of RT-PCR test positivity compared to the use of the classical nucleic acid amplification test. In our study, the lack of SARS-CoV-2 vaccination and older age were independently associated with a longer RT-PCR positivity..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Renal replacement therapy - 9(2023), 1 vom: 21. Juli |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Alfano, Gaetano [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
© The Author(s) 2023 |
---|
doi: |
10.1186/s41100-023-00487-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR052340805 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR052340805 | ||
003 | DE-627 | ||
005 | 20230722064806.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230722s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s41100-023-00487-y |2 doi | |
035 | |a (DE-627)SPR052340805 | ||
035 | |a (SPR)s41100-023-00487-y-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Alfano, Gaetano |e verfasserin |0 (orcid)0000-0003-0591-8622 |4 aut | |
245 | 1 | 0 | |a Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2023 | ||
520 | |a Background The weakened immune system of patients on hemodialysis (HD) may prolong SARS-CoV-2 infection compared to the general population. Current international guidelines recommend ending isolation in conjunction with serial testing in moderately and severely immunocompromised subjects. This study aimed to estimate SARS-CoV-2 infectivity by measuring RT-PCR test positivity in HD patients. A comparison between RT-PCR test and cycle threshold (Ct) value has been performed as a secondary endpoint. Methods A single-center retrospective study was conducted at the University of Modena (Italy) from March 2020 to October 2022. Only patients on chronic HD therapy with COVID-19 were enrolled in the study. In our HD Center, two negative nasopharyngeal reverse transcription polymerase chain reaction (RT-PCR) results were used to end quarantine in this population. SARS-CoV-2 RT-PCR test positivity duration measured the time elapsed from a positive RT-PCR to a second negative test. Ct cut-off of 35 cycles was used to definite “high Ct value,” a condition characterized by a large number of cycles of PCR amplification to register a positive RT-PCR test. Results During the observational period, 159 cases of SARS-CoV-2 infections were diagnosed in 151 patients. Median age was 70.1 (54.3–81.6) years and males accounted for 59.6% of the COVID-19 population. Median duration of SARS-CoV-2 RT-PCR test positivity on the nasal mucosa accounted for 30 (IQR, 21–40.5) days. Unvaccinated patients experienced significantly longer RT-PCR test positivity compared to vaccinated patients (42 [IQR,31–56] vs. 28 [IQR,20–35.7] days; p = < 0.001). The use of high Ct value, a laboratory surrogate of SARS-CoV-2 replication, anticipated a negative RT-PCR test of 9 (IQR, 6–12) days. Multivariate linear regression analysis showed that increased age (β coefficient 0.31; confidence interval [CI] 95%, 0.14—0.43; p = < 0.001) and the lack of anti-SARS-CoV-2 vaccination (β 0.49 CI95%, 11.9–22.5; p = < 0.001) were predictors of a prolonged RT-PCR positivity. Conclusions Patients with COVID-19 on HD had prolonged RT-PCR test positivity. The adoption of “high Ct value” criteria led to a significant reduction in the duration of RT-PCR test positivity compared to the use of the classical nucleic acid amplification test. In our study, the lack of SARS-CoV-2 vaccination and older age were independently associated with a longer RT-PCR positivity. | ||
650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
650 | 4 | |a Vaccine |7 (dpeaa)DE-He213 | |
650 | 4 | |a Mortality |7 (dpeaa)DE-He213 | |
650 | 4 | |a SARS-COV-2 |7 (dpeaa)DE-He213 | |
650 | 4 | |a Virus shedding |7 (dpeaa)DE-He213 | |
650 | 4 | |a Ct value |7 (dpeaa)DE-He213 | |
650 | 4 | |a RT-PCR |7 (dpeaa)DE-He213 | |
650 | 4 | |a Hemodialysis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Virus hesitancy |7 (dpeaa)DE-He213 | |
650 | 4 | |a Hospitalization |7 (dpeaa)DE-He213 | |
700 | 1 | |a Morisi, Niccolò |4 aut | |
700 | 1 | |a Ferri, Camilla |4 aut | |
700 | 1 | |a Fontana, Francesco |4 aut | |
700 | 1 | |a Giovanella, Silvia |4 aut | |
700 | 1 | |a Ligabue, Giulia |4 aut | |
700 | 1 | |a Mori, Giacomo |4 aut | |
700 | 1 | |a Franceschini, Erica |4 aut | |
700 | 1 | |a Ferrari, Annachiara |4 aut | |
700 | 1 | |a Gregorini, Mariacristina |4 aut | |
700 | 1 | |a Cappelli, Gianni |4 aut | |
700 | 1 | |a Tagliazucchi, Sara |4 aut | |
700 | 1 | |a Pecorari, Monica |4 aut | |
700 | 1 | |a Guaraldi, Giovanni |4 aut | |
700 | 1 | |a Magistroni, Riccardo |4 aut | |
700 | 1 | |a Donati, Gabriele |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Renal replacement therapy |d [London] : BioMed Central, 2015 |g 9(2023), 1 vom: 21. Juli |w (DE-627)SPR038245647 |w (DE-600)2866852-2 |x 2059-1381 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2023 |g number:1 |g day:21 |g month:07 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s41100-023-00487-y |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 9 |j 2023 |e 1 |b 21 |c 07 |